SHSE:603882 (China)
Â
Class A
Â¥
26.69
+0.32 (+1.21%)
Jul 20
Business Description
Guangzhou Kingmed Diagnostics Group Co Ltd
ISIN : CNE100002VW1
Share Class Description:
SHSE:603882: Class ATotal Employee Number:
9,529Compare
Compare
Traded in other countries / regions
603882.China Index Membership
SSE Composite IndexCSI 500 IndexCSI 300 IndexCSI 500 Index IPO Date
2017-09-08Description
Founded in 1994, KingMed is the largest independent clinical laboratory in China. It was listed on the Shanghai Stock Exchange in 2017. As of 2024, KingMed has 50 centralized labs and provides over 4000 test items. Over 90% of its total revenue comes from clinical diagnostics. Furthermore, KingMed has been actively investing in its cold chain logistics. Its service network covers the most intensely populated areas in China.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 2.74 | |||||
Equity-to-Asset | 0.69 | |||||
Debt-to-Equity | 0.14 | |||||
Debt-to-EBITDA | -12.37 | |||||
Interest Coverage | 17.36 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 4.55 | |||||
Beneish M-Score | -3.38 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -27 | |||||
3-Year EBITDA Growth Rate | -60 | |||||
3-Year FCF Growth Rate | -11.2 | |||||
3-Year Book Growth Rate | -7.7 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 7.59 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 59.92 | |||||
9-Day RSI | 61.43 | |||||
14-Day RSI | 59.1 | |||||
3-1 Month Momentum % | -11.1 | |||||
6-1 Month Momentum % | -24.1 | |||||
12-1 Month Momentum % | -16.84 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.13 | |||||
Quick Ratio | 3.04 | |||||
Cash Ratio | 1.19 | |||||
Days Inventory | 17.94 | |||||
Days Sales Outstanding | 234.52 | |||||
Days Payable | 150.08 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 3.31 | |||||
Dividend Payout Ratio | 3.33 | |||||
3-Year Dividend Growth Rate | -11.7 | |||||
Forward Dividend Yield % | 6.61 | |||||
5-Year Yield-on-Cost % | 20.07 | |||||
3-Year Average Share Buyback Ratio | 0.3 | |||||
Shareholder Yield % | 2.64 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 35.15 | |||||
Operating Margin % | 4.07 | |||||
Net Margin % | -1.74 | |||||
EBITDA Margin % | -1.17 | |||||
FCF Margin % | 12.95 | |||||
OCF Margin % | 20.13 | |||||
ROE % | -1.53 | |||||
ROA % | -1.07 | |||||
ROIC % | 4.46 | |||||
3-Year ROIIC % | 160.82 | |||||
ROC (Joel Greenblatt) % | -1.69 | |||||
ROCE % | -0.92 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 36.31 | |||||
PE Ratio without NRI | 101.1 | |||||
Shiller PE Ratio | 15.7 | |||||
PS Ratio | 2.13 | |||||
PB Ratio | 1.95 | |||||
Price-to-Tangible-Book | 2.02 | |||||
Price-to-Free-Cash-Flow | 16.33 | |||||
Price-to-Operating-Cash-Flow | 10.52 | |||||
EV-to-EBIT | -158.73 | |||||
EV-to-Forward-EBIT | 29.55 | |||||
EV-to-EBITDA | -158.73 | |||||
EV-to-Forward-EBITDA | 15.82 | |||||
EV-to-Revenue | 1.86 | |||||
EV-to-Forward-Revenue | 1.76 | |||||
EV-to-FCF | 14.38 | |||||
Price-to-GF-Value | 0.96 | |||||
Price-to-Projected-FCF | 1.01 | |||||
Price-to-Graham-Number | 3.01 | |||||
| Price-to-Net-Current-Asset-Value | 3.71 | |||||
Earnings Yield (Greenblatt) % | -0.63 | |||||
FCF Yield % | 6.19 | |||||
Forward Rate of Return (Yacktman) % | 0.5 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Guangzhou Kingmed Diagnostics Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 5,914.925 | ||
| EPS (TTM) (Â¥) | -0.22 | ||
| Beta | 1.9629 | ||
| 3-Year Sharpe Ratio | -0.72 | ||
| 3-Year Sortino Ratio | -1 | ||
| Volatility % | 28.27 | ||
| 14-Day RSI | 59.1 | ||
| 14-Day ATR (Â¥) | 1.278988 | ||
| 20-Day SMA (Â¥) | 24.46 | ||
| 12-1 Month Momentum % | -16.84 | ||
| 52-Week Range (Â¥) | 21.5 - 40.68 | ||
| Shares Outstanding (Mil) | 463.26 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Guangzhou Kingmed Diagnostics Group Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Guangzhou Kingmed Diagnostics Group Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-10-30 | In 102 days | ||
| Second quarter earnings results for 2026 | 2026-08-21 | In 32 days | ||
| General meeting for 2025 | 2026-06-29 14:00 | 22.16 (-5.78%) | ||
| Annual report for 2025 | 2026-04-25 | 28.28 (-1.63%) | ||
| First quarter earnings results for 2026 | 2026-04-25 | 28.28 (-1.63%) | ||
| CNY 0.880000 Cash Dividend | 2026-02-05 | 32.16 (+1.77%) | ||
| Third quarter earnings results for 2025 | 2025-10-30 | 29.02 (-0.14%) | ||
| Second quarter earnings results for 2025 | 2025-08-22 | 30.35 (-0.91%) | ||
| General meeting for 2024 | 2025-06-09 14:30 | 30.00 (+0.64%) | ||
| First quarter earnings results for 2025 | 2025-04-26 | 27.64 (-4.16%) |
Show
Entries
Guangzhou Kingmed Diagnostics Group Co Ltd Frequently Asked Questions
What is Guangzhou Kingmed Diagnostics Group Co Ltd(SHSE:603882)'s stock price today?
The current price of SHSE:603882 is ¥26.69. The 52 week high of SHSE:603882 is ¥40.68 and 52 week low is ¥21.50.
When is next earnings date of Guangzhou Kingmed Diagnostics Group Co Ltd(SHSE:603882)?
The next earnings date of Guangzhou Kingmed Diagnostics Group Co Ltd(SHSE:603882) is 2026-08-21 Est..
Does Guangzhou Kingmed Diagnostics Group Co Ltd(SHSE:603882) pay dividends? If so, how much?
The Dividend Yield %  of Guangzhou Kingmed Diagnostics Group Co Ltd(SHSE:603882) is 3.31% (As of Today), Highest Dividend Payout Ratio of Guangzhou Kingmed Diagnostics Group Co Ltd(SHSE:603882) was 3.33. The lowest was 0.04. And the median was 0.18. The  Forward Dividend Yield % of Guangzhou Kingmed Diagnostics Group Co Ltd(SHSE:603882) is 6.61%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Guangzhou Kingmed Diagnostics Group Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers